Malaria News and Research

Latest Malaria News and Research

GS-9620 therapy suppresses hepatitis B virus infection

A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.

29 Apr 2013

U.N. urges sustained support for prevention, treatment activities on World Malaria Day

On World Malaria Day (April 25), the U.N. "warned ... that malaria maintains its impact on less developed countries, mainly in Africa, where millions of people lack needed attention," and in a message marking the day, U.N. Secretary-General Ban Ki-moon "urged political leaders and health authorities of states where malaria is endemic to keep their commitment to achieve universal access to prevention and treatment of malaria".

26 Apr 2013

Opinion pieces published in recognition of World Malaria Day

Wednesday is World Malaria Day, observed annually on April 25. This year's theme is "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.

26 Apr 2013

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.

26 Apr 2013

U.S. CDC, FDA, armed forces taking action to fight malaria

Testifying before Congress this week, CDC Director Thomas Frieden "said the challenge in the fight against malaria, which in Africa alone kills one child every minute, is staying one step ahead of the malaria parasite" and "cited the need for better public health surveillance, and urged Congress to fund better detection tools".

26 Apr 2013

USAID blog highlights World Malaria Day

"Time and again, we see the same predictable cycle in public and private sector programs all over the world. Success turns the volume down on the alarm bells that drive the investments that produced that success in the first place, and when that happens, only failure raises the alarm again".

26 Apr 2013

Financial Times publishes special report on malaria

The Financial Times has published a special report (.pdf) on malaria featuring articles examining issues including prevention, treatment and research and development (R&D).

26 Apr 2013

Blog examines independent evaluation of PMI

While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results.

26 Apr 2013

Sustained funding for malaria efforts needed to maintain momentum

"When in the year 2000 African leaders first decided to put a Malaria Day on the calendar of the world, the ravages of malaria were barely visible to global decision-makers in prosperous countries," Fatoumata Nafo-Traor, executive director of the Roll Back Malaria (RBM) Partnership and a former minister of health in Mali, writes in the Huffington Post's "The Big Push" blog.

25 Apr 2013

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.

25 Apr 2013

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Devex features a sponsored interview with Dennis Broun, executive director of UNITAID, which uses innovative financing and "its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income countries."

25 Apr 2013

Malaria approaches must be adjusted to account for local contexts, 'changing realities'

Noting "April 25 marks World Malaria Day, an opportunity for those who work to defeat the illness to review progress and renew commitments," Laurence Slutsker and Patrick Kachur of the CDC's Division of Parasitic Diseases and Malaria, write in a Malaria Journal opinion piece, "After a decade of steady success, this year's commemoration of the date is also an opportunity to reconsider current approaches and assess the state of the science needed to keep pace in the global effort to combat malaria."

25 Apr 2013

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.

25 Apr 2013

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

On World Malaria Day, 25 April, WHO recognizes significant accomplishments in preventing and controlling malaria, including in high-burden countries in sub-Saharan Africa, but highlights the threat of antimalarial drug resistance in south-east Asia's Greater Mekong subregion, where an emergency response is now being launched.

25 Apr 2013

Study identifies malaria parasite protein as potential new target for drug treatment to prevent malaria

Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.

24 Apr 2013

Rapid Assessment of Malaria device provides faster, more accurate diagnostic test

There, the pitch by company CEO John R. Lewandowski, who opened with the line, "What if I told you I could save one million lives every year with just refrigerator magnets and a laser pointer?", got raves and a replay on Fortune Magazine/CNN online.

24 Apr 2013

AfriCoLeish receives grant from European Union to test new treatments for kala-azar

Research and development (R&D) project, AfriCoLeish, is supported by the European Union Seventh Framework Programme (EU FP7) through a grant of -3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.

23 Apr 2013

Partnership and accountability among countries will lead to global health successes

In remarks at the Africa Health Forum on Friday in Washington, D.C., Deputy Secretary of State William Burns discussed the evolution of foreign assistance and cooperation "from a donor-recipient relationship to more of a partnership," according to a speech transcript provided by the U.S. State Department.

23 Apr 2013

Global Fund working to fight malaria in Latin America

In the ONE blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about how the Global Fund to Fight AIDS, Tuberculosis and Malaria is working to prevent malaria in Latin America.

23 Apr 2013

New collaboration to expand vaccine approaches for melanoma

Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.

23 Apr 2013

Malaria News and Research

Latest Malaria News and Research

GS-9620 therapy suppresses hepatitis B virus infection

U.N. urges sustained support for prevention, treatment activities on World Malaria Day

Opinion pieces published in recognition of World Malaria Day

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

U.S. CDC, FDA, armed forces taking action to fight malaria

USAID blog highlights World Malaria Day

Financial Times publishes special report on malaria

Blog examines independent evaluation of PMI

Sustained funding for malaria efforts needed to maintain momentum

Three steps to eliminating NTDs

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Malaria approaches must be adjusted to account for local contexts, 'changing realities'

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

Study identifies malaria parasite protein as potential new target for drug treatment to prevent malaria

Rapid Assessment of Malaria device provides faster, more accurate diagnostic test

AfriCoLeish receives grant from European Union to test new treatments for kala-azar

Partnership and accountability among countries will lead to global health successes

Global Fund working to fight malaria in Latin America

New collaboration to expand vaccine approaches for melanoma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in